Stock Analysis
Embry Holdings Full Year 2023 Earnings: HK$0.17 loss per share (vs HK$0.12 loss in FY 2022)
Embry Holdings (HKG:1388) Full Year 2023 Results
Key Financial Results
- Revenue: HK$1.28b (down 3.9% from FY 2022).
- Net loss: HK$72.2m (loss widened by 41% from FY 2022).
- HK$0.17 loss per share (further deteriorated from HK$0.12 loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Embry Holdings' share price is broadly unchanged from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 2 warning signs for Embry Holdings you should be aware of, and 1 of them can't be ignored.
Valuation is complex, but we're helping make it simple.
Find out whether Embry Holdings is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:1388
Embry Holdings
Embry Holdings Limited, an investment holding company, designs, researches, develops, manufactures, trades in, and sells ladies brassieres, panties, swimwear, and sleepwear.
Adequate balance sheet and slightly overvalued.